GoodRx Holdings, Inc. (GDRX) Analyse boursière

Présentation de l'entreprise

GoodRx Holdings, Inc. operates within the United States healthcare sector, specifically serving the health information services industry by providing a price comparison platform that allows consumers to compare prescription drug costs and save on their purchases. The enterprise currently employs a workforce of 697 individuals and maintains a market capitalization of $733.11M, reflecting its position as a mid-sized entity within the broader healthcare data ecosystem. Annually, the company generates revenue totaling $796.85M, which establishes a significant operational footprint despite the specialized nature of its information services model. These valuation and revenue figures indicate that the company has achieved substantial scale, yet the relatively modest market cap compared to its revenue suggests a specific market positioning or investor sentiment regarding its growth trajectory and profitability metrics.

Santé financière

The company reports trailing twelve-month revenue of $796.85M, net income of $30.44M, and EBITDA of $122.31M, highlighting a significant disparity between gross earnings before interest and taxes and the final bottom line. This substantial gap between revenue and net income reveals a cost structure where operating expenses, including cost of sales and overhead, consume the majority of the top-line revenue before reaching the profit margin. Free cash flow stands at $81.94M, providing the organization with considerable financial flexibility to fund operations, service debt obligations, or pursue strategic initiatives without immediate reliance on external capital markets. The gross margin is reported at 92.8%, indicating a highly scalable business model where the cost of goods sold is minimal relative to sales, while the operating margin of 19.0% and profit margin of 3.8% demonstrate the impact of operating leverage and expense management on the final profitability. On the balance sheet, cash holdings of $261.82M are contrasted against total debt of $542.81M, resulting in a debt-to-equity ratio of 88.08, which signifies a highly leveraged financial structure where liabilities significantly exceed equity. Despite the high leverage, the current ratio of 2.61 indicates robust short-term liquidity, suggesting the company possesses more than enough current assets to cover its short-term liabilities comfortably. Return on equity is measured at 4.5% and return on assets at 4.8%, metrics that reveal the current effectiveness of management in generating returns relative to the capital employed and the total asset base.

Évaluation de la valorisation

Trailing twelve-month earnings yield corresponds to a P/E ratio of 23.78, while the forward P/E is significantly lower at 5.82, implying that the market anticipates a substantial increase in future earnings or that current earnings are suppressed by temporary factors not reflected in forward estimates. The price-to-book ratio stands at 1.18, indicating that the stock trades at a slight premium over its book value, suggesting that investors are willing to pay more than the net asset value per share. Alternative valuation metrics such as the price-to-sales ratio of 0.92 and an EV/EBITDA of 8.29 provide context for the company's valuation relative to its revenue generation and cash-flow-producing capabilities, suggesting a valuation that is sensitive to earnings volatility. The stock has traded within a 52-week range with a high of $5.81 and a low of $1.77, meaning the current price sits at a level that reflects significant volatility within this historical band. The beta of 1.47 indicates that the stock exhibits higher price volatility than the broader market, moving with greater intensity than the general equity index during periods of market stress or rally.

Growth & Income

Year-over-year revenue growth is recorded at -1.9%, while earnings growth is reported at -9.7%, demonstrating that earnings are contracting at a faster rate than revenue, which often points to declining operating margins or one-time cost increases affecting the bottom line more severely. The company does not distribute dividends, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning the organization retains all of its earnings rather than distributing them to shareholders. This reinvestment strategy suggests that the company prioritizes internal growth initiatives or debt reduction over immediate income generation for investors. The overall growth and income profile presents a challenging picture characterized by negative growth in both revenue and earnings, combined with a lack of dividend income, which requires careful analysis of the underlying operational drivers for the decline.